QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report “AI Fetal Ultrasound View Detection Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global AI Fetal Ultrasound View Detection Software market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for AI Fetal Ultrasound View Detection Software was estimated to be worth US$ 326 million in 2025 and is projected to reach US$ 924 million, growing at a CAGR of 16.1% from 2026 to 2032.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6605134/ai-fetal-ultrasound-view-detection-software
AI Fetal Ultrasound View Detection Software Market Summary
1. Definition
AI fetal ultrasound view detection software refers to intelligent analysis systems built on deep learning algorithms, designed to be embedded into obstetric ultrasound workflows for automatic identification, classification, and quality assessment of fetal anatomical structures and standard planes. These systems typically cover standard plane recognition for fetal head, abdomen, femur, cardiac views, spine, and facial structures, providing real-time feedback on image quality and completeness. The core value is to algorithmically standardize measurement procedures, reduce operator-dependent variability, and improve detection rates for complex structural abnormalities. From a technical architecture perspective, these platforms generally employ convolutional neural networks for real-time inference on dynamic ultrasound images, supporting cloud-based, on-premise, or hybrid deployment options.
2. Overall Industry Development
The global AI fetal ultrasound view detection software market is currently in a rapid expansion phase, positioning itself at a leading level among global medical software segments. In terms of business models, the market primarily adopts a hybrid pricing approach combining device-end licensing with cloud-based algorithm subscriptions.
The industry is currently at a critical juncture transitioning from technical validation to scaled commercial application. Multiple products have received regulatory approvals from major markets including the US Food and Drug Administration. Furthermore, the industry is evolving from an auxiliary screening tool toward an intelligent risk stratification and clinical decision support system.
North America currently holds the largest market share, attributed to its advanced healthcare infrastructure, high technology acceptance, and robust reimbursement systems. The Asia-Pacific region represents the fastest-growing market, driven by a large maternity population, healthcare digital transformation, and active domestic product development.
Figure00001. Global AI Fetal Ultrasound View Detection Software Market Size (US$ Million), 2021-2032
Above data is based on report from QYResearch: Global AI Fetal Ultrasound View Detection Software Market Report 2022-2031 (published in 2025). If you need the latest data, plaese contact QYResearch.
Figure00002. Global AI Fetal Ultrasound View Detection Software Top 14 Players Ranking and Market Share (Ranking is based on the revenue of 2025, continually updated)
Above data is based on report from QYResearch: Global AI Fetal Ultrasound View Detection Software Market Report 2025-2031 (published in 2025). If you need the latest data, plaese contact QYResearch.
4. Favorable Factors
Strong clinical demand is driven by congenital birth defects remaining a leading cause of neonatal mortality, with screening effectiveness heavily dependent on operator experience. AI serves as an untiring second pair of eyes, significantly improving efficiency.
Technological progress has made accurate recognition from complex ultrasound images possible, with leading products achieving regulatory approval from authorities such as the FDA.
Supportive policies include AI-assisted services being included as reimbursable items under ultrasound examinations in some markets like China.
Healthcare digital transformation is reducing technical barriers for AI integration, with telemedicine creating new application scenarios.
5. Unfavorable Factors
Technical limitations include algorithm generalizability boundaries, with performance potentially degrading when deployment environments differ substantially from training conditions. Current systems are primarily applicable to standard plane screening scenarios, with limited capability for complex or rare abnormalities.
Clinical acceptance issues include resistance from experienced sonographers who have developed established habits and ingrained routines, concerns about skill degradation from over-reliance on AI, and worries about legal liability in cases where AI errors occur.
Integration obstacles for third-party vendors include compatibility challenges across different equipment brands, with older devices lacking digital video output capabilities.
Ethical and legal uncertainties include liability attribution for missed abnormalities, data privacy concerns, and algorithm explainability issues.
6. Entry Barriers
Technological barriers require integration across computer vision, deep learning, medical image processing, ultrasound physics, and clinical obstetrics. Data acquisition and annotation are critical, requiring long-term clinical partnerships and extensive expert annotation time.
Regulatory barriers involve complex, time-consuming approval processes from authorities such as the FDA, CE, and NMPA, requiring substantial clinical evidence and resources.
Commercialization barriers include long sales cycles in hospital procurement, reliance on partnerships with ultrasound equipment manufacturers for market penetration, and payment uncertainties where reimbursement remains limited in many regions.
7. Industry Chain
The upstream segment includes data resources, where high-quality annotated ultrasound images are fundamental for model training, and computing infrastructure, requiring powerful GPU resources.
The midstream segment is the industry core, transforming data and computing into usable software products. Participants include large medical device companies, AI-focused startups, and academic spin-offs. Business models vary from software licensing and subscriptions to device-based licensing and software-plus-service models.
The downstream segment includes tertiary hospitals, secondary hospitals and private facilities, and primary healthcare institutions. Application scenarios include routine prenatal screening, targeted examinations, training and education, and telemedicine.
Value distribution places algorithm development and clinical validation at the highest value, followed by data resources and channel access. Future trends include vertical integration, evolving coopetition between device manufacturers and software vendors, and increasing price pressure on undifferentiated products.
The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.
The AI Fetal Ultrasound View Detection Software market is segmented as below:
By Company
Sonio (Samsung Medison)
BrightHeart
Fraiya
Diagnoly
DeepEcho Inc.
GE Healthcare
Siemens Healthineers
Butterfly Network
Canon Medical Systems
Fujifilm Healthcare
Clarius Mobile Health
EchoNous
Exo AI
Esaote
Segment by Type
On-Premise / Cart-Based
Cloud-Based SaaS
Edge / Handheld Device
Segment by Application
Hospitals (Radiology/OB-GYN Departments)
Outpatient Ultrasound Clinics
Maternal-Fetal Medicine Practices
Point-of-Care / Remote Settings
Each chapter of the report provides detailed information for readers to further understand the AI Fetal Ultrasound View Detection Software market:
Chapter 1: Introduces the report scope of the AI Fetal Ultrasound View Detection Software report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of AI Fetal Ultrasound View Detection Software manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various AI Fetal Ultrasound View Detection Software market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of AI Fetal Ultrasound View Detection Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of AI Fetal Ultrasound View Detection Software in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Benefits of purchasing QYResearch report:
Competitive Analysis: QYResearch provides in-depth AI Fetal Ultrasound View Detection Software competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.
Industry Analysis: QYResearch provides AI Fetal Ultrasound View Detection Software comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.
and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.
Market Size: QYResearch provides AI Fetal Ultrasound View Detection Software market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.
Other relevant reports of QYResearch:
Global AI Fetal Ultrasound View Detection Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global AI Fetal Ultrasound View Detection Software Market Research Report 2026
Global AI Fetal Ultrasound View Detection Software Market Outlook, In‑Depth Analysis & Forecast to 2032
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
